Method for the diagnosis of neuromyelitis optica

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9588115
SERIAL NO

14780617

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to a method for the diagnosis and/or risk stratification of neuromyelitis optica (abbreviated NMO), wherein a determination from a body sample of a patient/test subject is performed by means of artificial aquaporin-4 peptides. The invention further relates to a kit and to new artificial aquaporin-4 peptides as such.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
ONCIMMUNE GERMANY GMBH44227 DORTMUND

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Göhler, Heike Bochum, DE 8 5
Lüking, Angelika Bochum, DE 18 7
Müllner, Stefan Langenfeld, DE 5 5
Rengers, Petra Münster, DE 2 0

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Sep 7, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00